specialized compounded options were used historically for flexible dosing until regulatory restrictions changed in 2025
You can download the current version here: To view or add a comment, sign in The Brazilian Patent and Trademark Office (BRPTO) has officially released Normative Ordinance #80/2026, setting new rules for "New Uses of Known Products." Post-filing Data: A major win
Gradual dose titration is fundamental to minimising side effects
According to YourProtocol, many people use both peptides as part of their "Dual-System Protocol." However, anyone considering peptide use should consult with a qualified healthcare practitioner familiar with peptide bioregulators
Someone with insulin resistance, elevated fasting glucose, and fatty liver disease may lose weight rapidly once tirzepatide improves insulin action and reduces hepatic fatwhereas someone with normal glucose metabolism might lose weight more gradually because tirzepatide's primary lever (improved insulin sensitivity) has less room to operate
Singh, B., Doyle, M., Weaver, C., Koyano-Nakagawa, N
